Showing results (1001-1010 of 1,211) with videos related to

Sort By:
Pageof 122
European Journal of Heart Failure|September 2, 2022
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trialJohn W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation|August 16, 2022
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HFKieran F Docherty, Paul Welsh, Subodh Verma, et al.
Journal of the American College of Cardiology|May 20, 2021
Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HFJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
JACC. Heart Failure|August 4, 2018
Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical TrialsKishan S Parikh, Kavita Sharma, Mona Fiuzat, et al.
ESC Heart Failure|February 19, 2026
Efficacy of aficamten according to geographic location of patients with hypertrophic obstructive cardiomyopathyCaroline J Coats, Theodore Abraham, Roberto Barriales-Villa, et al.
The New England Journal of Medicine|April 1, 2014
Survival with cardiac-resynchronization therapy in mild heart failureIlan Goldenberg, Valentina Kutyifa, Helmut U Klein, et al.
The New England Journal of Medicine|April 11, 2014
Spironolactone for heart failure with preserved ejection fractionBertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
Pageof 122